Regeneron
Regeneron is a biotechnology company that develops and commercializes medicines for the treatment of metabolic, inflammatory and infectious diseases.
Business Model:
Revenue: $12.2B
Employees: 10,001-999,999
Industries / Tags:
Detailed Regeneron Information
Geographic Data
Address: 777 Old Saw Mill River Road
City: Tarrytown
State: NY
Zip: 10591
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$9M
Raised Total:$9M
Social
Metrics
377,270Website Global Rank
144,382Website Monthly Traffic
Twitter Followers
Description
Regeneron is a biotechnology company that develops and commercializes medicines for the treatment of metabolic, inflammatory and infectious diseases.
Contact Phone:
+19148477000
Contact Email:
Regeneron went public on 4/12/1991 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/12/1991
Ticker Symbol:
REGN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2022 | Vyriad | Series B | 0 |
| 6/2020 | DNAnexus | Series G | 0 |
| 9/2019 | Adicet Bio | Series B | 0 |
| 6/2018 | Decibel Therapeutics | Series C | 55M |
| 4/2019 | Alnylam Pharmaceuticals | Post-IPO Equity | 0 |
| 1/2023 | 2seventy bio | Post-IPO Equity | 20M |
| 5/2022 | Vyriad | Series B | 0 |
| 6/2020 | DNAnexus | Series G | 0 |
| 9/2019 | Adicet Bio | Series B | 0 |
| 4/2019 | Alnylam Pharmaceuticals | Post-IPO Equity | 0 |
| 6/2018 | Decibel Therapeutics | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2016 | Post-IPO Equity | 1 | $8.9M |
U.S. Department of Health &a; Human Services U.S. Department of Health &a; Human Services U.S. Department of Health &a; Human Services U.S. Department of Health &a; Human Services |
6/1988 | Angel | $1M | 1/1991 | IPO | $91.6M | 8/2020 | Post-IPO Debt | $2B |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 4/2022 | Checkmate Pharmaceuticals |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
